Published 22 September 2009, doi:10.1136/bmj.b3532
Cite this as: BMJ 2009;339:b3532

Research

Economic evaluation of arthritis self management in primary care

Anita Patel, senior lecturer1, Marta Buszewicz, senior lecturer2, Jennifer Beecham, principal research fellow, professor of health and social care economics3,4, Mark Griffin, lecturer2, Greta Rait, senior clinical lecturer2,5, Irwin Nazareth, professor2,5, Angela Atkinson, clinical trial officer6, Julie Barlow, professor of health psychology, research director7, Andy Haines, director, professor of public health and primary care8

1 Centre for the Economics of Mental Health, Institute of Psychiatry, King’s College London, London SE5 8AF, 2 Research Department of Primary Care and Population Health, University College London School of Life and Medical Sciences, 3 Personal Social Services Research Unit, London School of Economics and Political Science, 4 Personal Social Services Research Unit, University of Kent, Canterbury, Kent, 5 MRC General Practice Research Framework, London, 6 North East Stroke Research Network, James Cook University Hospital, Middlesbrough, 7 Self-management Programme, Applied Research Centre in Health and Lifestyle Interventions, Faculty of Health and Life Sciences, Coventry University, 8 London School of Hygiene and Tropical Medicine

Correspondence to: A Patel anita.patel{at}iop.kcl.ac.uk

Objective To assess the cost effectiveness of a self management programme plus education booklet for arthritis in primary care.

Design Cost effectiveness and cost utility analysis from health and social care and societal perspectives alongside a randomised controlled trial.

Setting 74 general practices in the United Kingdom.

Participants 812 patients aged 50 or more with osteoarthritis of the hips or knees, or both, and pain or disability, or both.

Interventions Randomisation to either six sessions of an arthritis self management programme plus an education booklet (intervention group) or the education booklet alone (standard care control group).

Main outcome measures Total health and social care costs and total societal costs at 12 months; cost effectiveness (incremental cost effectiveness ratios and cost effectiveness acceptability curves) on basis of quality of life (SF-36, primary outcome measure), EuroQol visual analogue scale, and quality adjusted life years (QALYs).

Results At 12 months health and social care costs in the intervention group were £101 higher (95% confidence interval £3 to £176) than those in the control group because the additional costs of the arthritis self management programme did not seem to be fully offset by savings elsewhere. There were no significant differences in societal costs (which were up to 13 times the size of health and social care costs) or any of the outcomes. From the health and social care perspective the intervention was dominated by the control on the basis of QALYs (which were non-significantly lower in the intervention group) and had incremental cost effectiveness ratios between £279 and £13 473 for the other outcomes. From the societal perspective the intervention seemed superior to the control owing to non-significantly lower costs and non-significantly better outcomes on all measures except QALYs. Probabilities of the arthritis self management programme’s cost effectiveness ranged between 12% and 97% (for thresholds ranging £0 to £1000) based on one point improvements in SF-36 outcomes, but the clinical significance of this is debatable. Probabilities of cost effectiveness on the basis of the visual analogue scale and QALYs were low.

Conclusions Cost effectiveness of an arthritis self management programme is not suggested on the basis of current National Institute for Health and Clinical Excellence cost perspectives and QALY thresholds. The probability of cost effectiveness is greater when broader costs and other quality of life outcomes are considered. These results suggest that the cost effectiveness of the Department of Health’s expert patients programme cannot be assumed across all clinical conditions and that further rigorous evaluations for other conditions may be needed.

Trial registration Current Controlled Trials ISRCTN79115352 [controlled-trials.com] .


This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

How effective are expert patient (lay led) education programmes for chronic disease?
Chris Griffiths, Gill Foster, Jean Ramsay, Sandra Eldridge, and Stephanie Taylor
BMJ 2007 334: 1254-1256. [Extract] [Full Text] [PDF]

Self management of arthritis in primary care: randomised controlled trial
Marta Buszewicz, Greta Rait, Mark Griffin, Irwin Nazareth, Anita Patel, Angela Atkinson, Julie Barlow, and Andy Haines
BMJ 2006 333: 879. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ